UAB Looking For A Variety Of Patients For COVID-19 Clinical Trials
Infectious disease doctors at UAB said Tuesday they’re still looking for COVID-19 patients to join a number of clinical trials.
Currently, UAB is offering both inpatient and outpatient trials ranging from vaccines to treatments aimed at lessening the effects of the virus.
Dr. Sonya Heath, a professor of medicine in UAB’s Division of Infectious Diseases, said some of the outpatient trials could appeal to patients because they only require a single dose, four in-person visits and virtual check-ins.
One of the trials currently accepting patients involves convalescent plasma treatments, which take antibodies from recovered patients and injects them into patients who have COVID or those who have come into close contact with the virus.
“We are really asking the question: If you give high concentrations of antibody, is that beneficial in decreasing the severity of the illness and decreasing the likelihood that somebody will be hospitalized,” Heath said.
Other studies have shown that patients do better if their bodies generate an immune response to the virus.
“They have a shorter course of illness and their viral load is lower,” Heath said. “We know that generating an immune response is a good thing and decreases your symptoms and severity. Each of these studies … is looking at ways to transfer an immune response to you in some form or fashion.”
Dr. Turner Overton, from UAB’s outpatient COVID-19 clinic, says patients should enroll in clinical trials because it gives them a more heightened level of clinical care.
“We’re gaining knowledge and we have expertise here at UAB,” Overton said. “But if people sit at home and wait until they’re really sick, in the second week of illness, you know, the complications are much higher.”
UAB is looking for COVID-19 patients with varying degrees of symptoms.
Editor’s Note: UAB holds WBHM’s broadcast license but our news and business departments operate independently.
An ape, a tea party — and the ability to imagine
The ability to imagine — to play pretend — has long been thought to be unique to humans. A new study suggests one of our closest living relatives can do it too.
How much power does the Fed chair really have?
On paper, the Fed chair is just one vote among many. In practice, the job carries far more influence. We analyze what gives the Fed chair power.
This complex brain network may explain many of Parkinson’s stranger symptoms
Parkinson's disease appears to disrupt a brain network involved in everything from movement to memory.
‘Please inform your friends’: The quest to make weather warnings universal
People in poor countries often get little or no warning about floods, storms and other deadly weather. Local efforts are changing that, and saving lives.
Immigration officials to testify before House as DHS funding deadline approaches
Congressional Democrats have a list of demands to reform Immigration and Customs Enforcement. But tensions between the two parties are high and the timeline is short – the stopgap bill funding DHS runs out Friday.
How the use of AI and ‘deepfakes’ play a role in the search for Nancy Guthrie
As artificial intelligence becomes more advanced and commonplace, it can be difficult to know what's real and what's not, which has complicated the search for Nancy Guthrie, according to law enforcement. But just how difficult is it?
